AGN-242428 in the Treatment of Plaque Psoriasis

Summary

The purpose of this study is to evaluate the efficacy, safety, tolerability, pharmacokinetics and pharmacodynamics of 3 doses of AGN-242428 in adult participants with moderate to severe plaque-type psoriasis.

Timeline

Start

2017-11-15

Primary completion

2018-03-22

Completion

2018-04-20

Drugs

Indications